financetom
Business
financetom
/
Business
/
Penumbra Gets CE Mark for Computer Assisted Vacuum Thrombectomy Technologies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Penumbra Gets CE Mark for Computer Assisted Vacuum Thrombectomy Technologies
Sep 16, 2024 7:32 AM

10:13 AM EDT, 09/16/2024 (MT Newswires) -- Penumbra (PEN) said Monday it received the CE Mark in Europe for its computer-assisted vacuum thrombectomy technologies Lightning Flash 2.0 and Lightning Bolt 7.

The technologies are used to remove clots in the vascular system, the company said.

Penumbra said the products will assure doctors in Europe that computer-assisted vacuum thrombectomy is a reliable initial choice for treating diseases including pulmonary embolism, venous thrombosis, and sudden limb ischemia.

Shares of Penumbra rose 1% in recent trading.

Price: 188.89, Change: +1.95, Percent Change: +1.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Penumbra Gets CE Mark for Computer Assisted Vacuum Thrombectomy Technologies
Penumbra Gets CE Mark for Computer Assisted Vacuum Thrombectomy Technologies
Sep 16, 2024
10:13 AM EDT, 09/16/2024 (MT Newswires) -- Penumbra (PEN) said Monday it received the CE Mark in Europe for its computer-assisted vacuum thrombectomy technologies Lightning Flash 2.0 and Lightning Bolt 7. The technologies are used to remove clots in the vascular system, the company said. Penumbra said the products will assure doctors in Europe that computer-assisted vacuum thrombectomy is a...
Immatics Ends Collaboration With Bristol-Myers to Co-Develop IMA401 Targeting Melanoma-Associated Antigen
Immatics Ends Collaboration With Bristol-Myers to Co-Develop IMA401 Targeting Melanoma-Associated Antigen
Sep 16, 2024
07:59 AM EDT, 09/16/2024 (MT Newswires) -- Immatics ( IMTX ) said Monday it has ended its partnership with Bristol-Myers Squibb ( BMY ) to co-develop IMA401, targeting melanoma-associated antigen, because of current portfolio prioritization within the latter. The current partnership and license agreement, initially signed in 2021, will end on Dec. 12, the company added. Under the terms, Immatics...
SunCar Technology's H1 Net Loss Widens; Revenue Rises
SunCar Technology's H1 Net Loss Widens; Revenue Rises
Sep 16, 2024
07:42 AM EDT, 09/16/2024 (MT Newswires) -- SunCar Technology ( SDA ) reported an H1 net loss Monday of $0.67 per diluted share, wider than the $0.04 loss a year earlier. Analyst estimates were not available for comparison. Revenue for the six months ended June 30 was $203.1 million, up from $159.4 million a year earlier. ...
Mattr Signs Definitive Agreement to Sell Its Brazilian Pipe Coating Business to Vallourec For US$17.5 Million
Mattr Signs Definitive Agreement to Sell Its Brazilian Pipe Coating Business to Vallourec For US$17.5 Million
Sep 16, 2024
07:44 AM EDT, 09/16/2024 (MT Newswires) -- Mattr Corp. ( MTTRF ) on Monday entered into a definitive agreement to sell its subsidiary, Thermotite do Brazil, to Vallourec Tubular Solutions, a subsidiary of Vallourec S.A.. A statement noted Thermotite provides thermal insulation pipe coating services to the offshore oil and gas industry from its plant in Serra, Brazil and is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved